Emre OCAK, Deniz KOCAÖZ, Mehtap ACAR, Baran ACAR

Comparison of risk factors in newborn hearing screening in a developing country

The aim of this study is to evaluate the results of the newborn-hearingscreening program (NHSP) in our institute, investigate the risk factors andtheir correlation to congenital hearing loss (CHL). Newborns who admittedto our clinic for NHSP from June 2014 to December 2014 were included inthe study. After the test parents were asked to fill a questionnaire aboutthe risk factors of CHL. Test results and referral rate were compared withrisk factors. One thousand consecutive babies were included in the study.The overall referral rate was 3.5%. Mechanic ventilation, history of familialCHL and familial consanguinity were found to be significantly related toCHL.In the light of our results we can conclude that getting access to everynewborn for hearing screening is mandatory and targeting the risk factors andinforming the family about the follow-up period is important for diagnosingthe delayed hearing impairment.

PDF

___

1. Ozturk B, Genc GA. Maturation of auditory brainstem responses in babies from birth to 6 months of age. TurkiyeKlinikleri J Med Sci 2012; 32: 677-686.
2. Ohl C, Dornier L, Czajka C, Chobaut JC, Tavernier L. Newborn hearing screening on infants at risk. Int J Pediatr Otorhinolaryngol 2009; 73: 1691-1695.
3. Joint Committee on Infant Hearing 1994 Position Statement. Otolaryngol Head Neck Surg1995; 113: 191-196.
4. Joint Committee on Infant Hearing of the American Academy of Pediatrics. Supplement to the JCIH 2007 position statement: principles and guidelines for early intervention after confirmation that a child is deaf or hard of hearing. Pediatrics 2013; 131: 1324-1349.
5. Norton SJ, Gorga MP, Widen JE. Identification of neonatal hearing impairment: summary and recommendations. Ear Hear 2000; 21: 529-535.
6. Konukseven O, Dincol I, Genc GA. Automated auditory brainstem response: a proposal for an initial test for healthy newborn hearing screening with a focus on the test time. Int Adv Otol 2012; 8: 419-425.
7. Garabli H, Genc GA, Kayikci ME, et al. Hearing screening protocols for babies with hearing loss risk factors in Turkey. Int Adv Otol 2010; 6: 216-222.
8. Cebulla M, Hofmann S, Shehata-Dieler W. Sensitivity of ABR based newborn screening with the MB11 BERAphone(®). Int J Pediatr Otorhinolaryngol 2014; 78: 756-761.
9. Paludetti G, Ottaviani F, Fetoni AR, Zuppa AA, Tortorolo G. Transient evoked otoacustic emissions (TEOAEs) in new-borns: normative data. Int J Pediatr Otorhinolaryngol 1999; 47: 235-241.
10. American Academy of Pediatrics Joint Committee on Infant Hearing: Position Statement. Pediatrics 1982; 70: 496-497.
11. Downs MP. Universal newborn hearing screening the Colorado story. Int J Pediatr Otorhinolaryngol 1995; 32: 257-259.
12. Bolat H, Genç GA. National newborn hearing screening in Turkey: history and principles. Türkiye Klinikleri J E.N.T. 2012; 5: 11-14.
13. Övet G, Isik Balcı Y, Canural R. Yenidoğan işitme tarama sonuçlarımız. Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi 2010; 11: 27-29.
14. Bolat H, Bebitoglu FG, Ozbas S Altunsu AT, Kose MR. National newborn hearing screening program in Turkey: struggles and implementations between 2004 and 2008. Int J Pediatr Otorhinolaryngol 2009; 73: 1621-1623.
15. Erturk BB, Genc GA, Ozkan S. Comparison of hearing screening protocols for universal newborn hearing screening in Turkey. Int Adv Otol 2010; 6: 223-230.
16. Genc GA, Barmak E. Yenidoğan işitme taramasının konjenital işitme kayıplı bebeğin gelişimine etkisi. Turkiye Klinikleri J Med Sci2012; 32: 1284-1294.
17. Karaca CT, Oysu C, Toros SZ Naiboğlu B, Verim A. Is hearing loss in infants associated with risk factors? Evaluation of the frequency of risk factors. Clin Exp Otorhinolaryngol 2014; 7: 260-263.
18. Ant A, Karamert R, Bayazıt YA. Genetics of hearing loss and current status in Turkey. Türkiye Klinikleri J E.N.T. Special Topics 2012;5: 15-20.
19. Bielecki I, Horbulewicz A, Wolan T. Risk factors associated with hearing loss in infants: an analysis of 5282 referred neonates. Int J Pediatr Otorhinolaryngol 2011; 75: 925-930.
20. Galambos R, Despland PA. The auditory brainstem response (ABR) evaluates risk factors for hearing loss in the newborn. Pediatr Res 1980; 14: 159-163.
21. Cebulla M, Shehata-Dieler W. ABR-based newborn hearing screening with MB11 BERAphone® using an optimized chirp for acoustical stimulation. Int J Pediatr Otorhinolaryngol 2012; 76: 536-543.
22. Olusanya BO. Can the world’s infants with hearing loss wait? Int J Pediatr Otorhinolaryngol 2005; 69: 735-738.